Managing the Rising Costs of GLP-1 Drugs with Data-Driven Insights

glpi1-case-study


The rising use of Ozempic and other GLP-1 drugs for non-diabetic weight loss poses a significant challenge for employers managing health plan costs.

  • Spot inappropriate usage
  • Take targeted action
  • Monitor trends proactively

Explore the full story

New ideas, proven best practices, and fresh perspectives for the healthcare ecosystem.

  • Transforming Benefits Data to Improve Health Outcomes

    Discover in this case study see how BenInsights unified fragmented health data across carriers, resulting in targeted cancer screening initiatives with extraordinary results for…

    Read More
  • Revenue Revival: A Rural Hospital’s Path to Sustainable Success

    Claritev’s Provider Strategy and Data Insight Services helped a rural healthcare organization overcome mounting financial pressures, care and access hurdles, competitive disadvantages, and fragmented…

    Read More
  • Employer Guide: Identify Potential Health Plan Savings

    Discover how data-driven insights can help you identify and deploy the best point solutions for your health plan members.

    Read More